BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16715073)

  • 1. High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia.
    Al Kuraya K; Siraj AK; Bavi P; Al-Jomah N; El-Solh H; Ezzat A; Al-Dayel F; Belgaumi A; Al-Kofide A; Sabbah R; Sheikh S; Amr S; Simon R; Sauter G
    Mod Pathol; 2006 Aug; 19(8):1124-9. PubMed ID: 16715073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.
    Al-Kuraya K; Narayanappa R; Siraj AK; Al-Dayel F; Ezzat A; El Solh H; Al-Jommah N; Sauter G; Simon R
    Hum Pathol; 2006 Jun; 37(6):742-8. PubMed ID: 16733216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
    Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
    Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
    Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
    Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
    Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
    Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
    Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma.
    Kameoka Y; Tagawa H; Tsuzuki S; Karnan S; Ota A; Suguro M; Suzuki R; Yamaguchi M; Morishima Y; Nakamura S; Seto M
    Oncogene; 2004 Dec; 23(56):9148-54. PubMed ID: 15480422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
    Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
    Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.
    Yoshida S; Nakamura N; Sasaki Y; Yoshida S; Yasuda M; Sagara H; Ohtake T; Takenoshita S; Abe M
    Mod Pathol; 2005 Mar; 18(3):398-405. PubMed ID: 15492762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
    Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; Calabrò E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
    Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
    Hong FZ; Wang B; Li HM; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
    Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
    Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
    Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
    Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma.
    Takada S; Morita K; Hayashi K; Matsushima T; Sawamura M; Murakami H; Nojima Y
    Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
    Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
    Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma.
    Esteller M; Gaidano G; Goodman SN; Zagonel V; Capello D; Botto B; Rossi D; Gloghini A; Vitolo U; Carbone A; Baylin SB; Herman JG
    J Natl Cancer Inst; 2002 Jan; 94(1):26-32. PubMed ID: 11773279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic implications of tissue inhibitor of metalloproteinase-1-positive diffuse large B-cell lymphoma.
    Choi JW; An JS; Lee JH; Lee ES; Kim KH; Kim YS
    Mod Pathol; 2006 Jul; 19(7):963-73. PubMed ID: 16648868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.